Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The CT order is interesting. I imagine we'll see PR maybe soon regarding partnership or distro agreement or hopefully some other good news.
If they can at least duplicate result from last quarter to next quarter then I think you'll see more serious money coming in to stay. The LSU purchase only tells me they see surgical center's also adopting trxc platform but to what degree who knows. Baby steps .
Anybody see or hear anything from presentation today in NY?
Notice that Sugarbeat website has been updated and "mid 2018" has been redacted and "2018" now takes it's place,nothing to see here? Hopefully update on CE approval or milestone list is released soon or by end of May.
@maley63 All very good points and I pretty much concur. Let's hope it's a case of bringing in significant investor to turbo charge distro July thru end of year and not a hiccup that hasn't been released to the public yet.Its easy to lose sight of the fact that equities have been on a rollercoaster the past few weeks and Nemaura is fresh meat with a lot to prove very soon. Let's hope for positive PR followed by CE apporoval by mid May.
It is confusing but can't really trade up on what could be steady stream of good news over the next 7 weeks until it actually happens,that's just prudent investing period. I'm actually equally surprised it traded in the $5-$6 range as long as it did instead of trading with the overall market especially with no significant revenue or product on store shelves yet.
So that being said, the volume seems pretty low imo for what's looking like 35-40% haircut so far these past few weeks. Maybe the stock is being walked down to pick-up investor to raise capital? A big injection of cash would be useful for greater production capacity,sales team, European launch outside of Uk and support clinical trials/manufacturing here in U.S. ? If this is worth a lick , gets CE approval and they actually have something on the shelves in the UK by end of June this stock should take off.
Interesting price move( DOWN) since adding the PR firm RG yesterday, hopefully an anomaly that gets turned around with good buzz in investment community and press releases. Let's hope they are stellar at what they do !
What's the whisper number ,1 machine sold lolol j/k I'm actually hoping for 4 or 5 with a few intent to buy letters hopefully!
@Lintin Nemaura's story should seemingly get interesting by the end of April or May . It seems that they should have CE notification of approval(if approved) by that time assuming it was submitted late January.Its pure conjecture on my part but why not play it safe on otc (as apposed to uplisting to NASDAQ)UNLESS you were really certain you had something to bring to market and go primetime ?
At this point Echo's IP could be property of noteholder's?
@Lintin . This is true . Certainly a successful non invasive cgm would greatly lift Echo IP and make it pretty attractive. Did Echo actually have fda approval for any generation of cgm to be actually commercialized?
Now that Evan is married to a supermodel he needs to have her friends counter the negativity and Tweet how much they love and actually use Snap ??Come on already,fire with fire!!! ?? I'm curious what next quarter's numbers would've been without the timely petition/negativity surrounding redesign after such a nice quarterly report. The petition site seems legit, with real people and not flooded by bots from some dark backroom somewhere. I'm guessing running classic version next to redesign would be cost prohibitive or impossible? Come on Snap time to generate some steady and timely PR of your own!
Hopefully good news March 6th backed by sales already completed or coming if even a handful, or I think a haircut is coming . Obviously FDA approval for new procedures would be positive
@Lintin Not a word but their website still up and Alan is still listed with phone# I can't imagine Echo pulling off a miracle especially with Nemaura uplisting to NASDAQ and apparently waiting on CE approval now for their cgm
The link looks legit actually and so does video on (embedded link). Just seems that single port(Intuitive) with less operating room realestate taken up and wristed instruments is winning the war here . Am I missing something?
Anyone know precisely when CE was submitted? Looks like end of April at earliest for trade-able news if submitted end of January?
!!!! That was quick !!!Great Press Release !!! Well done Nemaura!!!
It would be nice to know why projected release date has moved to mid 2018 for UK and presumably everywhere else. Obviously this should knock stock price down to 4's or high 3's without press release or further explanation.
They never had a cgm or drug delivery system with fda approval that was even close to ready for primetime, it's the only logical explanation I can think of.
I thought transdermal meds fell under "pharma" but honestly not sure. I noticed in most recent press release they mentioned Sugarbeat as "lead product" so not sure if they are including pharma under the "medical" umbrella as well. Obviously transdermal delivery of daily medications is a blockbuster in the making .
Probably range bound (from now until mid to end of Feb maybe) before CE approval? Would be nice to see retail packaging on Sugarbeat site when that happens.
What is the price difference between daVinci and Senhance?
Nevermind , again more copycats . You are developing cool features and platform that anyone can just take and make their own ? !!https://seekingalpha.com/news/3325247-bloomberg-twitter-planning-snapchat-style-video-tool
Could be because VP of Product leaving Snap which will be viewed as someone jumping ship even tho he states clearly he wants to pursue his passions outside of tech. Snap is a sitting duck until it puts up better numbers and finds more ways to leverage this technology and minimize the copycats. They need to plug the leaks too!
It's too far behind the eightball at this point unless someone has been continuing work all this time unannounced or has a boat load of money to look at the carcass and salvage the pieces. Nemaura on the other hand about to go primetime,let's see what happens.
Second uplisting in as many months,sounds like they are pretty confident they will have a cgm with CE approval to ship out soon. This uplisting should bring analyst coverage and institutional/retail investors that would otherwise be off limits to otc.
Bam!!!https://finance.yahoo.com/news/nemaura-medical-inc-announces-uplisting-140000596.html
Nemaura Medical Inc. , a medical technology company developing the wireless sugarBEAT® non-invasive continuous glucose monitoring system for adjunctive use by persons with diabetes, today announced that its shares of common stock were approved for listing on the NASDAQ Capital Market.
Looks like this thing about to have life support unplugged
https://finance.yahoo.com/news/fibit-inc-invests-blood-glucose-153119494.html
Fitbit Inc (NASDAQ:FIT) confirmed that it has made its first investment in a startup, in an effort to beat Apple Inc.’s (NASDAQ:AAPL) Apple Watch. The Fitbit investment is in a company called Sano, which aims to develop a wearable, coin-sized blood sugar monitor for diabetics. FIT stock popped on the news on Friday morning, but is now down 2.5% shortly after the bell Monday morning.
Have a Happy and Prosperous New Year Ramad !
Thanks for info Ramad
Any rumors on this one?
Oh well end of 2017 launch seemed pretty optimistic especially with no manufacturing agreement in place by October? Hopefully the clinical trial data,CE submission and firmer launch date come in a press release by end of November.
Nice write-up in http://www.pharmaceutical-journal.com of SugarBeat with photo of transmitter in various colors!
www.SugarBeat.com
Clinical try milestone slip sliding away? Are they using transmitter with disposable batteries for clinical trials or waiting for production to ramp up and use rechargeable transmitter?
So does this lower the the defenses for MTIA to claim IP or open door to possible deal ?
Ya gotta like their chances considering this is not their first rodeo and already have one device approved . If they meet their milestones for August and September we should be off to the races ,until then hopefully some positive updates via PR.